Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

NYMX 3.60 -0.09 (-2.44%)
price chart
Is Nymox Pharmaceutical Corporation (NASDAQ: NYMX) About To Bring Fexapotide ...
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) plans to seek regulatory approval to market fexapotide as a treatment for prostate cancer.
What's Ahead for Nymox Pharmaceutical Corporation After Today's Huge Decline?
The stock of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a huge mover today! About 263,653 shares traded hands. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has risen 7.61% since December 21, 2015 and is uptrending.
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Related articles »  
Stock to keep an eye on: Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
By looking at Nymox Pharmaceutical Corporation (NYMX) YTD (year to date) performance, the stock shows Negative value of -3.66%.
Nymox Pharmaceutical Corp (NYMX) Files Form 4 Insider Buying : James George ...  Market Digest
Review the Analyst's Considerable Price Target Suggestions: AbbVie Inc ...  Is stories
/quotes/zigman/3870025/realtime
Nymox Pharmaceutical Corp. NASDAQ: NYMX. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Healthcare Insider Roundup: Nymox Pharmaceutical Corporation & More
In my very first LCP Daily Insider Note, I observed that Nymox Pharmaceutical Corporation (NASDAQ:NYMX) was one of a few particularly interesting long-opportunities to watch in the coming weeks.
Biotech Beat: Pfizer (PFE), Nymox Pharmaceutical Corporation (NYMX), Gilead ...
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) On Monday, Nymox Pharmaceutical Corporation announced that the long-term extension prospective double-blind Phase 3 BPH studies NX02-0017 and NX02-0018 of fexapotide triflutate, also known ...
Why Nymox Pharmaceutical Took Off
Nymox Pharmaceutical Corp. (NASDAQ: NYMX) shares made solid headway in Wednesday's session on positive results from a cancer trial.
Nymox Pharmaceutical Corp. (NYMX) Is Sharply Higher On Study Results  RTT News
Nymox Pharma Shares Rise 27% Off Trade Halt; Prostate Cancer Treatment Seen ...  Sonoran Weekly Review
Here's Why Nymox Pharmaceutical Corporation (NYMX) Stock Gained More Than 100%
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced the results of its long-term extension prospective, double-blind pivotal Phase 3 research today.
Nymox Pharmaceutical Corporation (NYMX) Jumps On News Of Study Results  Insider Monkey (blog)
Nymox Pivotal Phase 3 NX-1207 BPH Extension Trial Successfully Meets Primary ...  GlobeNewswire (press release)
Large Inflow of Money Witnessed in Nymox Pharmaceutical Corporation
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) : Wednesdays money flow data in Nymox Pharmaceutical Corporation (NASDAQ:NYMX) suggests that the bulls made the most of the weakness in the stock.